Washed platelets were stimulated in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IMBX) (100 µM), and drug-induced changes in platelet cyclic adenosine monophosphate (cAMP) levels were assessed as described before.23
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.